Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass screening and selective treatment for malaria in Indonesia
NCT01878357Phase 4Completed
- Sponsor
- Universitas Indonesia
- Start
- Jun 2013
- Primary completion
- Nov 2013
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of dihydroartemisinin + piperaquine, primaquine in malaria, sponsored by Universitas Indonesia. Started Jun 2013; status: completed.
02
Drugs
dihydroartemisinin + piperaquineprimaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT01878357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01878357.